In a big leap towards atmanirbhar Bharat, the CSIR today declared to have developed indigenous technology for producing paracetamol, which is widely used as a pain reliever and fever reducer. The announcement has been made by Union Minister Dr. Jitendra Singh in the 40th Foundation Day of the Department of Scientific and Industrial Research in New Delhi.Key Takeaways

1. Indigenous Paracetamol Technology:

2. This new development aims to reduce India's dependence on imported raw materials for the production of paracetamol.

3. The Satya Deeptha Pharmaceuticals Ltd, a Karnataka-based company, will employ this technology for indigenous production.

  2.  Atmanirbhar Bharat:

• The project is in tandem with the vision of Prime Minister Narendra Modi of a self-reliant India, "Atmanirbhar Bharat."

• It is likely to significantly bring down the cost of production and increase access.

  3.  Recent Indigenous Developments:

• India has developed its first indigenous antibiotic, Nafithromycin, which will combat drug-resistant bacteria.

• The country successfully carried out its first gene therapy trial for Haemophilia.

  4.   Technology Transfer Success:
On DSIR's 40th Foundation Day, 16 new CSIR technologies were transferred to MSMEs under the "100 Days, 100 Technologies" campaign. 

5.  CSIR's Continued Achievements:
Some of the key achievements included the development of the hydrogen bus, biofuels, and lavender cultivation under the Aroma Mission.

Impact on India's Pharmaceutical Landscape:
Self-Sufficiency in Medicinal Production: This development further consolidates India's position in the pharmaceutical industry, playing a vital role in global medicament production.

• Boost for MSMEs: Technologies handed over through the Laghu Udyog Bharati will boost small-scale industries

• National Autonomy in Imports: With paracetamol now mass-produced in India, the country will no longer be dependent on imported supplies.

Quotes

• Dr. Jitendra Singh :

“This innovation not only ensures self-reliance in essential drug production but also showcases the collaborative success of government and industry in fostering technological advancements.”

• Prof. A.K. Sood, Principal Scientific Advisor to the Government of India:

“We must transition from being a service economy to a product-based economy driven by indigenous designs and innovations.”The breakthrough of CSIR in paracetamol production marks a watershed moment for India's pharmaceutical industry in furthering the country's quest for self-reliance. With several technological advancements and innovations lined up, 2025 promises to be another transformative year for India's science and technology landscape.